GW Professor’s Research Contributes to Warning Added to Label of the Drug, Propecia

GW Professor, Dr. Michael Irwig, author of a 2011 study published in the Journal of Sexual Medicine, titled, “Persistent Sexual Side Effects of Finasteride for Male Pattern Hair Loss,” is available to speak with media about the recent changes required by the FDA to include a warning about possible persistent sexual side effects on packaging of the drug, Propecia. Dr. Irwig continues to study men with long-term effects of this drug.

B-Roll of Dr. Irwig talking about the 2011 study is on YouTube.


Dr. Michael Irwig

Michael S. Irwig, M.D., F.A.C.E., is an assistant professor of Medicine in the GW School of Medicine and Health Sciences and director of the Center for Andrology at the Medical Faculty Associates. Dr. Irwig is a general endocrinologist with a particular interest and expertise in androgens.

He is a well-published author with his research appearing in multiple journals including the Journal of Sexual Medicine, Diabetic Medicine, and the Journal of Clinical Endocrinology and Metabolism.  His research has been featured in many national and international mainstream publications and broadcast outlets including:  CBS News, MSNBC.com, CNN, Men’s Health Magazine, Men’s Journal and The Philadelphia Inquirer.

Dr. Irwig lectures at medical schools and medical centers across the country on the topics of male hypogonadism, vitamin D deficiency, use and abuse of anabolic steroids, and the endocrine care of transsexuals. He also serves as a reviewer for many academic medical journals.

Dr. Irwig is the Treasurer and a board member of the mid-Atlantic chapter of the American Association of Clinical Endocrinologists, as well as a member of the Endocrine Society.

Dr. Irwig received his M.D. degree from Cornell University and completed his residency in internal medicine at the University of Virginia. He was a senior fellow in endocrinology, metabolism, and nutrition at the University of Washington.

Latest News

Nofar Erlichman, PhD, a postdoctoral associate at the George Washington University School of Medicine and Health Sciences, was awarded a postdoctoral fellowship from the American Cancer Society for her project, “Adipocyte PD-L1 mediates the promotion of mammary tumor growth by the sympathetic…
The GW School of Medicine and Health Sciences welcomed the 2026 cohort of the Integrated Biomedical Sciences (IBS) PhD Program. Over the program’s 30-year history, GW has graduated 340 PhD who have gone on to careers across the biomedical sciences.
The GW Cancer Center announced the appointment of Katherine Chiappinelli, PhD, as Deputy Director for Basic Sciences. In this role, Chiappinelli will work with Edward Seto, PhD, associate center director for basic science at the GW Cancer Center, and the King Fahd Professor of Cancer Biology, to…